Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zixin Biqu Granules in Persistent Allergic Rhinitis
CTR20190600Phase 2Completed
- Sponsor
- Jiangsu Kanion Pharmaceutical Co., Ltd.
- Start
- Dec 2019
- Countries
- 1
01
Overview
A Phase 2 trial of Zixin Biqiu Granules in allergic rhinitis (AR), sponsored by Jiangsu Kanion Pharmaceutical Co., Ltd.. Started Dec 2019; status: completed.
02
Drugs
Zixin Biqiu Granules
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on CTR20190600.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20190600.